Delivery Order SPE2DX22D0010-SPE2D824FPH19

Award Date 7/22/24
Potential Completion Date 7/23/24
Potential Value $3K
Federal Agency
Medical Supply Chain
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, SPE2DX22D0010|SPE2D824FPZ09, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $3,183.45 firm fixed-price delivery order is for the supply of 15mg Amphetamine Mix (AD) Extended-Release Capsules. The award is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which allows Amerisourcebergen to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of amphetamine mix (amphetamine and dextroamphetamine) extended-release capsules in a 30mg dosage. The firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) Troop Support Medical, with a potential value of $2,321.20 and a period of performance through March 4, 2024. Amerisourcebergen Drug Corp is an established provider of pharmaceutical...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division, a major supplier of pharmaceutical products and medical supplies to the U.S. government. The award, valued at $2,526.20, is a delivery order contract for the provision of 30mg extended-release amphetamine mix capsules. The contract has a firm fixed-price pricing structure and a performance period ending on May 23, 2024. This award is...
This federal contract award, with ID SPE2DX22D0010|SPE2D824FQB46, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The $2,727.57 firm fixed-price delivery order is for the supply of 20mg Amphetamine Mix Extended-Release Capsules, a critical pharmaceutical product. This award is part of a larger Indefinite Delivery Contract (IDC) with a ceiling value of up to $999,999,999, which enables the DLA to efficiently...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,447.49 firm fixed-price delivery order is for the supply of 15mg extended-release amphetamine mix capsules. The contract is not set aside and is a part of Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle...
This federal contract award, with ID SPE2DX22D0010|SPE2D824FPL37, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,188.00 firm fixed-price delivery order is for the supply of Amphetamine Mix (AD) ER Capsules, 5mg. This contract is not designated as a set-aside. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through...
This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,008.00 firm-fixed-price delivery order is for the supply of 15mg amphetamine mix extended-release capsules, with a period of performance running through October 23, 2024. The award is a task order under Amerisourcebergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at...
This is a federal contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense (DoD), to Amerisourcebergen Drug Corp for the supply of 20mg Amphetamine Mix (AD) Extended-Release Capsules. The contract has a ceiling value of $2,148.24 and a period of performance through January 29, 2025. It is structured as a Delivery Order, with a Firm Fixed Price pricing type. The contract is not designated as a Set-Aside. Amerisourcebergen Drug Corp...
This federal contract award, valued at $1,782.07, was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of 30mg extended-release amphetamine medication capsules. It has an ultimate completion date of July 11, 2024. The contract is a firm fixed-price type and was awarded on a full and open competition basis without any set-aside designation....
This federal contract award, valued at $1,874.37, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract is for the delivery of Amphetamine Mix (AD) ER Capsules, 15mg, a pharmaceutical product. The contract is a Delivery Order under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 through December 2025. This IDC enables DLA to efficiently...
  • SPE2DX22D0010
    Indefinite Delivery Contract
  • SPE2DX22D0010-SPE2D824FPH19
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp (Contract No. SPE2DX22D0010|SPE2D824FPH19) is for the delivery of 15mg extended-release amphetamine mix capsules (AMPHETAMINE MIX (AD) ER CAPS 15MG). The $3,036.00 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a major customer of Amerisourcebergen's federal contracts. This delivery order is part of Amerisourcebergen's broader Indefinite Delivery Contract (IDC) with the DLA valued up to $999,999,999 through December 2025, which enables the agency to efficiently procure a wide range of pharmaceutical and medical supplies. The contract has an ultimate completion date of July 23, 2024 and does not utilize a set-aside designation.

Generated 10/21/24, 9:38 AM